Aloha is asking “how is that a price sensitive announcement?”. I am not replying to him/her/they, however anyone who is thinking the same and is not familiar with investing in medical development companies, every trial announcement is always price sensitive by default. And Aloha also learned something today from FLIESH
- Forums
- ASX - By Stock
- PNV
- Ann: First Patient enrolled - SynPath Diabetic Foot Ulcer Trial
Ann: First Patient enrolled - SynPath Diabetic Foot Ulcer Trial, page-20
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.61 |
Change
0.090(3.57%) |
Mkt cap ! $1.801B |
Open | High | Low | Value | Volume |
$2.59 | $2.66 | $2.58 | $3.183M | 1.217M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 19229 | $2.61 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.62 | 3084 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15952 | 2.610 |
2 | 1339 | 2.600 |
1 | 1945 | 2.570 |
1 | 5859 | 2.560 |
1 | 1636 | 2.550 |
Price($) | Vol. | No. |
---|---|---|
2.620 | 1636 | 1 |
2.630 | 3333 | 2 |
2.640 | 1636 | 1 |
2.650 | 19763 | 3 |
2.660 | 26946 | 5 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |